| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/26/1994 | WO1994009134A3 Modified ciliary neurotrophic factors |
| 05/26/1994 | WO1994008002A3 Methods and compositions for controlling translation of hcv proteins |
| 05/26/1994 | WO1994006909A3 A method of preventing tumor metastasis |
| 05/26/1994 | WO1994002510A3 Analogs of pth |
| 05/26/1994 | WO1994001558A3 Multimeric forms of members of the steroid/thyroid superfamily of receptors with the ultraspiracle receptor |
| 05/26/1994 | CA2626445A1 Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 05/26/1994 | CA2149771A1 Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle |
| 05/26/1994 | CA2149309A1 Heat shock proteins and the treatment of tumours |
| 05/26/1994 | CA2149212A1 Improved recombinant production of proteins having factor viii:c activity |
| 05/26/1994 | CA2149132A1 Specifically crosslinked hemoglobin with free functionality |
| 05/26/1994 | CA2149056A1 Novel polypeptides with opioid receptor activity, nucleic acids encoding these substances and uses thereof |
| 05/26/1994 | CA2148945A1 Cyclic compounds linked by a heterocyclic ring useful as inhibitors of platelet glycoprotein iib/iiia |
| 05/26/1994 | CA2148829A1 Avirulent live vaccine and method for immunizing animals against p. multocida pasteurellosis |
| 05/26/1994 | CA2148713A1 Allergenic proteins and peptides from japanese cedar pollen |
| 05/26/1994 | CA2148484A1 Novel cytokine designated elk ligand |
| 05/26/1994 | CA2148383A1 Peptide inhibitors of fibronectin and related collagen-binding proteins |
| 05/26/1994 | CA2147122A1 Biocidal chitin binding proteins |
| 05/26/1994 | CA2127531A1 Materials and methods for immunocontraception |
| 05/26/1994 | CA2126697A1 Opioid peptides |
| 05/26/1994 | CA2126690A1 Novel propoxyphene derivatives and protein and polypeptide propoxyphene derivative conjugates and labels |
| 05/26/1994 | CA2083812A1 Expression vectors and their use in the preparation of hiv-resistant human cells for therapeutic applications |
| 05/25/1994 | EP0598493A1 Recombinant vector, method for giving immunity against PVY-T to potato plant, and potato plant having immunity against PVY-T |
| 05/25/1994 | EP0598034A1 Production of peptide amides |
| 05/25/1994 | EP0598029A1 Retroviral vectors containing internal ribosome entry sites |
| 05/25/1994 | EP0598011A1 Ecdysteroid dependent regulation of genes in mammalian cells |
| 05/25/1994 | EP0598002A1 Viral vector-based insecticides and expression systems |
| 05/25/1994 | EP0598000A1 Method of diagnosing ovarian and endometrial cancer with monoclonal antibodies oxa and oxb |
| 05/25/1994 | EP0597997A1 Lanthionine bridged peptides |
| 05/25/1994 | EP0597984A1 Device for detecting aqueous contaminants |
| 05/25/1994 | EP0597960A1 Treatment of cell populations |
| 05/25/1994 | EP0597847A1 Synthetic senescent cell antigen |
| 05/25/1994 | EP0597845A1 GROWTH FACTOR WHICH INHIBITS THE GROWTH OF CELLS OVEREXPRESSING THE HUMAN ONCOGENE erbB-2 |
| 05/25/1994 | EP0597844A1 Target-specific, cytotoxic, recombinant pseudomonas exotoxin |
| 05/25/1994 | EP0597843A1 16 kDa SURFACE PROTEIN OF $i(P. FALCIPARUM) |
| 05/25/1994 | EP0597842A1 Metal binding proteins |
| 05/25/1994 | EP0597838A1 Vaccine compositions |
| 05/25/1994 | EP0597829A1 Novel monoclonal antibody to novel antigen associated with human tumors |
| 05/25/1994 | EP0358660B1 Synthetic inhibitors of mammalian collagenase |
| 05/25/1994 | EP0252146B1 Nuclear factors associated with transcriptional regulation |
| 05/25/1994 | EP0249629B1 Methods and materials for alleviation of pain symptoms of malignant neoplasia |
| 05/25/1994 | CA2109636A1 Process for preparing immunoconjugates |
| 05/25/1994 | CA2103323A1 Her4 human receptor tyrosine kinase |
| 05/24/1994 | US5315001 Acyl carrier protein - DNA sequence and synthesis |
| 05/24/1994 | US5315000 Gene encoding for a L5/3 growth factor and its CDNA |
| 05/24/1994 | US5314995 Antitumor |
| 05/24/1994 | US5314994 Inhibitor of tissue-type and urokinase-type plasminogen activators |
| 05/24/1994 | US5314992 Controlling immune and antiinflammatory response |
| 05/24/1994 | US5314991 Recombinant 40 KDa Dermatophagoides farinae allergen |
| 05/24/1994 | US5314873 Milk-protein hydrolyzates and compositions for use as hair and skin treating agent |
| 05/24/1994 | US5314872 Glucan sulfate, stabilized fibroblast growth factor composition |
| 05/24/1994 | US5314817 Catalytic and reactive polypeptides and methods for their preparation and use |
| 05/24/1994 | US5314813 Drosophila cell lines expressing genes encoding MHC class I antigens and B2-microglobulin and capable of assembling empty complexes and methods of making said cell lines |
| 05/24/1994 | US5314808 Method for the transformation of cells, particularly eukaryotes by a DNA originating from viruses of hepatitis, more particularly from virus of a B viral hepatitis, and preparations containing the expression products of said DNAs |
| 05/24/1994 | US5314807 Hypotensive agents |
| 05/24/1994 | US5314800 Purified human cytomegalovirus protein |
| 05/24/1994 | US5314695 Tissue factor based prothrombin time reagent |
| 05/24/1994 | CA1329862C Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors |
| 05/24/1994 | CA1329766C T cell epitopes of the hepatitis b virus nucleocapsid protein |
| 05/24/1994 | CA1329763C Stabilized fgf composition and production thereof |
| 05/24/1994 | CA1329762C Potentiation of erythropoiesis |
| 05/24/1994 | CA1329760C Plasma and recombinant protein formulations in high ionic strength media |
| 05/19/1994 | DE4306627C1 Method for increasing the sugar and starch content in plants - by a vector including transcription regulatory sequences and a cDNA fragment from Poty virus for inclusion proteins |
| 05/19/1994 | DE4241659C1 New thrombin-inhibiting protein - used in treatment of thrombosis, angina and arteriosclerosis |
| 05/19/1994 | DE4238416A1 Bestimmung von Peptidmotiven auf MHC-Molekülen Determination of peptide motifs on MHC molecules |
| 05/18/1994 | EP0597827A1 Fibroblast growth factor |
| 05/18/1994 | EP0597699A2 Protein secreted by cancer cells |
| 05/18/1994 | EP0597681A1 Expression vectors for the bovine trypsin and trypsinogen and host cells transformed therewith |
| 05/18/1994 | EP0597503A2 ECK receptor ligands |
| 05/18/1994 | EP0597185A1 Bacillus subtilis siderophore genes |
| 05/18/1994 | EP0597110A1 Method of detecting mesitylene-resistant staphylococcus aureus, novel peptide, and dna coding for same |
| 05/18/1994 | EP0597043A1 Porcine adipocyte antigens and their use in the immunological control of fat |
| 05/18/1994 | EP0597035A1 Highly stable recombinant yeasts for the production of recombinant proteins |
| 05/18/1994 | EP0597016A1 Infectious bursal disease virus recombinant poxvirus vaccine |
| 05/18/1994 | EP0597010A1 Transgenic protein production |
| 05/18/1994 | EP0597008A1 Improved expression of influenza a m2 protein in baculovirus and uses of m2 protein |
| 05/18/1994 | EP0596979A1 Recombinant plant viral nucleic acids |
| 05/18/1994 | EP0596969A1 Igf-ii analogues |
| 05/18/1994 | EP0596887A1 Genetically engineered mice containing alterations in the mhc class ii genes |
| 05/18/1994 | EP0596881A1 Expression in non-tumoral human lymphoblastoid lines with an integrative vector. |
| 05/18/1994 | EP0502872B1 Methods and materials for expression of human plasminogen variant |
| 05/18/1994 | EP0463043B1 Method for stabilizing the hybridization of complementary polynucleotide sequences |
| 05/18/1994 | EP0380495B1 Serum free media for the growth of insect cells and expression of products thereby |
| 05/18/1994 | EP0335899B1 Immunoaffinity purification system |
| 05/18/1994 | EP0328552B1 Thrombin derived polypeptides, compositions and methods for use |
| 05/18/1994 | EP0283475B1 Enhanced secretion of heterologous proteins by hosts using substituted promoters |
| 05/18/1994 | EP0248819B1 Recombinant fibroblast growth factors |
| 05/18/1994 | CN1086825A The present invention is concerned with tri- and tetracyclic compounds |
| 05/18/1994 | CN1086824A Calcium channel blocking polypeptide from agelenopsis aperta |
| 05/17/1994 | US5312912 Procedures and regulatory DNA sequences for genetically engineering disease resistance and other inducible traits in plants |
| 05/17/1994 | US5312911 Improved biological activity in the absence of heparin |
| 05/17/1994 | US5312903 Lysine-glycosylated recombinant interleukin-2 |
| 05/17/1994 | US5312902 Dimer of the precursor of HIV-2 envelope glycoprotein |
| 05/17/1994 | US5312901 Cloned streptococcal genes encoding protein G and their use to construct recombinant microorganisms to produce protein G |
| 05/17/1994 | US5312900 23K protein with binding specificity for queuine |
| 05/17/1994 | US5312810 Adenylate cyclase stimulating factor |
| 05/17/1994 | US5312809 Physiologically active substance derived from malt and process for the production thereof |
| 05/17/1994 | US5312808 Polyoxyethylene glycol conjugates with hemoglobin |
| 05/17/1994 | US5312752 Specific antibodies against the DNA-binding domain of and immunoassays to determine the presence and functional status of estrogen receptor proteins |
| 05/17/1994 | US5312747 Isolation, purification and utilization of sialidase-L in the synthesis of 2,7-anhydro-N-acetylneuraminic acid and for the selective cleavage of sialylα2-3 D-galactose linkage |
| 05/17/1994 | US5312738 Vancomycins |